{"id":371642,"title":"ACCESS Consortium: Points to consider for strain changes in authorised COVID-19 vaccines in an ongoing SARS-CoV2 pandemic - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:00:52.228000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/access-guidance-vaccines-strain-changes.html","snippet":"ACCESS Consortium: Points to consider for strain changes in authorised COVID-19 vaccines in an ongoing SARS-CoV2 pandemic On this page Executive summary Background Regulatory concepts for influenza virus vaccines Guidance for adapting authorised COVID-19 vaccines for SARS-CoV2…","rawSnapshotUrl":"/api/snapshots/raw/371642","browseUrl":"https://replay.healtharchive.ca/job-6/20260411150052/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/access-guidance-vaccines-strain-changes.html#ha_snapshot=371642","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}